Potential roles of oxidative distress on neurodegeneration in Parkinson's disease with neuropsychiatric symptoms

Potential roles of oxidative distress on neurodegeneration in Parkinson's disease with neuropsychiatric symptoms

BackgroundNeuropsychiatric symptoms (NPSs) belong to a category of non-motor symptoms of Parkinson's disease (PD), which seriously compromise the quality of life and prognosis of PD. This study focused on the correlations between NPSs, free radicals, neuroinflammatory factors, and neuropatholog...

Full description

Bibliographic Details
Main Authors:	Dan-ning Li, Teng-hong Lian, Wei-Jiao Zhang, Ya-nan Zhang, Peng Guo, Hui-ying Guan, Jing-hui Li, Ming-yue He, Wen-jing Zhang, Wei-jia Zhang, Dong-mei Luo, Xiao-min Wang, Wei Zhang
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-12-01
Series:	Frontiers in Aging Neuroscience
Subjects:	Parkinson's disease neuropsychiatric symptoms free radicals anti-oxidative enzyme neuropathological proteins cerebrospinal fluid
Online Access:	https://www.frontiersin.org/articles/10.3389/fnagi.2022.875059/full

Similar Items

Olfactory Dysfunction and Its Association With Neuropathologic Proteins in Cerebrospinal Fluid From Patients With Parkinson Disease
by: Peng Guo, et al.
Published: (2020-12-01)

Neuropsychiatric symptoms in untreated Parkinson’s disease
by: Szatmari S, et al.
Published: (2017-03-01)

Neuropsychiatric Symptoms in Parkinson’s Disease Dementia Are Associated with Increased Caregiver Burden
by: Yoon-Sang Oh, et al.
Published: (2015-01-01)

Acupuncture for the Treatment of Neuropsychiatric Symptoms in Parkinson's Disease: A Systematic Review and Meta-Analysis
by: Anxin Zhang, et al.
Published: (2024-03-01)

Parkinson’s Disease With Depression: The Correlations Between Neuroinflammatory Factors and Neurotransmitters in Cerebrospinal Fluid
by: Teng-hong Lian, et al.
Published: (2020-10-01)

Progression of Neuropsychiatric Symptoms over Time in an Incident Parkinson’s Disease Cohort (ICICLE-PD)
by: J. K. Dlay, et al.
Published: (2020-02-01)

Clinical Features and Potential Mechanisms Relating Neuropathological Biomarkers and Blood-Brain Barrier in Patients With Alzheimer’s Disease and Hearing Loss
by: Wei-jiao Zhang, et al.
Published: (2022-06-01)

Clinical uses of Bupropion in patients with Parkinson’s disease and comorbid depressive or neuropsychiatric symptoms: a scoping review
by: Matteo Vismara, et al.
Published: (2022-05-01)

Neuropsychiatric symptoms in patients with vascular dementia in mainland China
by: Jin Yan-ling, et al.
Published: (2015-01-01)

Neuropsychiatric Symptoms in Parkinson's Disease After Subthalamic Nucleus Deep Brain Stimulation
by: Weibing Liu, et al.
Published: (2021-05-01)

Prevalence and Risk Factors of Neuropsychiatric Symptoms in Institutionalized Patients with Parkinson’s Disease in Taiwan: A Nationwide Observational Study
by: Yang-Pei Chang, et al.
Published: (2023-01-01)

Neuropsychiatric symptoms and their impact on quality of life in multiple system atrophy
by: R. Ceponiene, et al.
Published: (2016-12-01)

Neuropsychiatric features, health-related quality of life, and caregiver burden in parkinson's disease
by: Atul Goel, et al.
Published: (2022-01-01)

The association between caregiver distress and individual neuropsychiatric symptoms of dementia
by: Annibal Truzzi, et al.

Persisting neuropsychiatric symptoms, Alzheimer’s disease, and cerebrospinal fluid cortisol and dehydroepiandrosterone sulfate
by: Sami Ouanes, et al.
Published: (2022-12-01)

The challenge of neuropsychiatric manifestations in parkinson’s disease. A case report
by: A. Cerame Del Campo, et al.
Published: (2021-04-01)

Efficacy and Safety of Rotigotine Transdermal Patch on Neuropsychiatric Symptoms of Parkinson's Disease: An Updated Meta-Analysis and Systematic Review
by: Junqiang Yan, et al.
Published: (2021-10-01)

Systemic and central nervous system neuroinflammatory signatures of neuropsychiatric symptoms and related cognitive decline in older people
by: Christopher Clark, et al.
Published: (2022-05-01)

Severity of Neuropsychiatric Symptoms in Nursing Home Residents
by: Anne-Sofie Helvik, et al.
Published: (2016-01-01)

Neuropsychiatric symptoms and severity of dementia
by: Gustavo Henrique de Oliveira Caldas, et al.

Treatment of apathy in Parkinson's disease: A bayesian network meta-analysis of randomised controlled trials
by: Aaron Shengting Mai, et al.
Published: (2024-02-01)

Neuropsychiatric Inventory domains cluster into neuropsychiatric syndromes in Alzheimer's disease: A systematic review and meta‐analysis
by: Shaun Kuan Wei Hiu, et al.
Published: (2022-09-01)

Neuropsychiatric Symptoms in Parkinson’s Disease Patients Are Associated with Reduced Health-Related Quality of Life and Increased Caregiver Burden
by: Hannah von Eichel, et al.
Published: (2022-01-01)

The Neuropsychiatric Inventory-Diary Rating Scale (NPI-Diary): A Method for Improving Stability in Assessing Neuropsychiatric Symptoms in Dementia
by: Francesca Morganti, et al.
Published: (2018-09-01)

The Comprehensive Analysis of Motor and Neuropsychiatric Symptoms in Patients with Huntington’s Disease from China: A Cross-Sectional Study
by: Yangfan Cheng, et al.
Published: (2022-12-01)

Cerebrospinal Fluid Analysis in Rheumatological Diseases with Neuropsychiatric Complications and Manifestations: A Narrative Review
by: Massimiliano Castellazzi, et al.
Published: (2024-01-01)

Neuropsychiatric symptoms in patients with thymoma-associated and non-thymoma myasthenia gravis
by: Carla Freeman, et al.
Published: (2014-07-01)

Neuropsychiatric Symptoms in Elderly Inpatients: A Multicenter Cross-Sectional Study
by: A. Mézière, et al.
Published: (2013-04-01)

Editorial: Neuroimaging of Cognitive and Neuropsychiatric Symptoms in Movement Disorders
by: Frederic Sampedro, et al.
Published: (2022-01-01)

Fluctuations in Parkinson’s disease and personalized medicine: bridging the gap with the neuropsychiatric fluctuation scale
by: Emmanuelle Schmitt, et al.
Published: (2023-08-01)

Missense mutation of angiotensin converting enzyme gene in an Alzheimer’s disease patient: a case report
by: Mingyue He, et al.
Published: (2024-03-01)

Characterization of neuropsychiatric symptoms in a group of individuals with manifest or pre-motor Huntington’s disease in Medellín, Colombia
by: D. Vasquez, et al.
Published: (2022-06-01)

Measuring neuropsychiatric symptoms in early dementia patients using speech analysis
by: A. König, et al.
Published: (2022-06-01)

Cyclophosphamide-induced seizures in a patient with neuropsychiatric systemic lupus erythematosus (NPSLE): A case report
by: Lingshu Zhang, et al.
Published: (2023-03-01)

Stress-Induced Functional Alterations in Amygdala: Implications for Neuropsychiatric Diseases
by: Xin Zhang, et al.
Published: (2018-05-01)

What evidence is there for implicating the brain orexin system in neuropsychiatric symptoms in dementia?
by: Giorgio Bergamini, et al.
Published: (2022-11-01)

Changes in neuropsychiatric symptoms and caregivers’ distress in behavioral variant frontotemporal dementia and Alzheimer’s disease in 12 months
by: M. Yassuda, et al.
Published: (2022-06-01)

Prevalence of Neuropsychiatric Symptoms across the Declining Memory Continuum: An Observational Study in a Memory Clinic Setting
by: Meiyan Zhang, et al.
Published: (2012-04-01)

Apathy-Related Symptoms Appear Early in Parkinson’s Disease
by: Emmie Cohen, et al.
Published: (2022-01-01)

Neuropsychiatric symptoms in cognitively normal older persons, and the association with Alzheimer’s and non-Alzheimer’s dementia
by: Tau Ming Liew
Published: (2020-03-01)